Reactivation of retinopathy of prematurity three years after treatment with bevacizumab

Amir R. Hajrasouliha, Jose M. Garcia-Gonzales, Michael J. Shapiro, Hawke Yoon, Michael P. Blair

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume48
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this